Patents by Inventor Wouter Korver

Wouter Korver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-SIGLEC-6 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20240084005
    Abstract: The present disclosure provides anti-Siglec-6 antibodies and their use in treating and preventing mast cell-mediated disorders, as well as compositions and kits comprising the anti-Siglec-6 antibodies.
    Type: Application
    Filed: June 30, 2023
    Publication date: March 14, 2024
    Inventors: Bradford A. YOUNGBLOOD, Julia SCHANIN, John LEUNG, Wouter KORVER, Thuy LUU, Emily C. BROCK
  • Anti-Siglec-7 antibodies having reduced effector function
    Patent number: 11912766
    Abstract: The invention provides methods and compositions for the treatment of cancer using anti-Siglec-7 antibodies that have reduced effector function.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: February 27, 2024
    Assignee: Allakos, Inc.
    Inventors: Christopher Bebbington, Wouter Korver, Nenad Tomasevic
  • Anti-Siglec-7 antibodies for the treatment of cancer
    Patent number: 11773162
    Abstract: The invention provides methods and compositions for the treatment of cancer using anti-Siglec7 antibodies.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: October 3, 2023
    Assignee: Allakos, Inc.
    Inventors: Christopher Bebbington, Wouter Korver, Nenad Tomasevic, Suzy El Bader, Kenneth Luehrsen
  • ANTI-CD38 BINDING DOMAINS
    Publication number: 20230203186
    Abstract: Provided in this disclosure are anti-CD38 binding domains, a composition comprising the anti-CD38 binding domains, nucleic acids encoding the anti-CD38 binding domains, and a method of using the anti-CD38 binding domains or the composition for treating multiple myeloma.
    Type: Application
    Filed: July 1, 2022
    Publication date: June 29, 2023
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Vinay Bhaskar, Erin Willert
  • ANTI-CD38 ANTIBODIES
    Publication number: 20230037373
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Application
    Filed: August 31, 2022
    Publication date: February 9, 2023
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar
  • Anti-CD38 antibodies
    Patent number: 11434304
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: September 6, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar
  • Anti-CD38 binding domains
    Patent number: 11414496
    Abstract: Provided in this disclosure are anti-CD38 binding domains, a composition comprising the anti-CD38 binding domains, nucleic acids encoding the anti-CD38 binding domains, and a method of using the anti-CD38 binding domains or the composition for treating multiple myeloma.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: August 16, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Vinay Bhaskar, Erin Willert
  • Fusions of antibodies to CD38 and attenuated interferon alpha
    Patent number: 10981986
    Abstract: The present invention provides a polypeptide construct comprising a peptide or polypeptide signaling ligand linked to an antibody or antigen binding portion thereof which binds to a cell surface-associated antigen, wherein the ligand comprises at least one amino acid substitution or deletion which reduces its potency on cells lacking expression of said antigen.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: April 20, 2021
    Assignee: Teva Pharmaceuticals Australia Pty Ltd
    Inventors: David S. Wilson, Jr., Sarah L. Pogue, Glen E. Mikesell, Tetsuya Taura, Wouter Korver, Anthony G. Doyle, Adam Clarke, Matthew Pollard, Stephen Tran, Jack Tzu Chiao Lin
  • ANTI-SIGLEC-7 ANTIBODIES HAVING REDUCED EFFECTOR FUNCTION
    Publication number: 20210054072
    Abstract: The invention provides methods and compositions for the treatment of cancer using anti-Siglec-7 antibodies that have reduced effector function.
    Type: Application
    Filed: January 11, 2019
    Publication date: February 25, 2021
    Inventors: Christopher Bebbington, Wouter Korver, Nenad Tomasevic
  • ANTI-CD38 BINDING DOMAINS
    Publication number: 20200231696
    Abstract: Provided in this disclosure are anti-CD38 binding domains, a composition comprising the anti-CD38 binding domains, nucleic acids encoding the anti-CD38 binding domains, and a method of using the anti-CD38 binding domains or the composition for treating multiple myeloma.
    Type: Application
    Filed: January 23, 2020
    Publication date: July 23, 2020
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Vinay Bhaskar, Erin Willert
  • ANTI-CD38 ANTIBODIES
    Publication number: 20200040105
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Application
    Filed: October 17, 2019
    Publication date: February 6, 2020
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar
  • CONJUGATED ANTI-CD38 ANTIBODIES
    Publication number: 20200031951
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Application
    Filed: May 14, 2019
    Publication date: January 30, 2020
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar
  • Anti-CD38 antibodies
    Patent number: 10494444
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: December 3, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar
  • Conjugated anti-CD38 antibodies
    Patent number: 10336833
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: July 2, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar
  • ANTI-SIGLEC-7 ANTIBODIES FOR THE TREATMENT OF CANCER
    Publication number: 20190194323
    Abstract: The invention provides methods and compositions for the treatment of cancer using anti-Siglec7 antibodies.
    Type: Application
    Filed: August 4, 2017
    Publication date: June 27, 2019
    Inventors: Christopher Bebbington, Wouter Korver, Nenad Tomasevic, Suzy El Bader, Kenneth Luehrsen
  • ANTI-CD38 ANTIBODIES
    Publication number: 20180066069
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Application
    Filed: September 13, 2017
    Publication date: March 8, 2018
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar
  • CONJUGATED ANTI-CD38 ANTIBODIES
    Publication number: 20180016349
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Application
    Filed: May 17, 2017
    Publication date: January 18, 2018
    Inventors: Kathleen Ann ELIAS, Gregory LANDES, Shweta SINGH, Wouter KORVER, Andrew Walling DRAKE, Mary HAAK-FRENDSCHO, Gyorgy Pal SNELL, Vinay BHASKAR
  • ANTIBODIES TO NTB-A
    Publication number: 20170334989
    Abstract: Anti-NTB-A antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind NTB-A and treat diseases, such as hematologic malignancies, which are characterized by expression of NTB-A.
    Type: Application
    Filed: February 7, 2017
    Publication date: November 23, 2017
    Inventors: Arie Abo, Wouter Korver
  • METHODS AND COMPOSITIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
    Publication number: 20170299590
    Abstract: The invention provides methods and compositions for the diagnosis, prognosis, and/or treatment response characterization of individuals suffering from systemic lupus erythematosus (SLE) using single cell network profiling.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 19, 2017
    Inventors: Rachael HAWTIN, Wouter KORVER, Erik EVENSEN
  • Anti-CD38 antibodies
    Patent number: 9790285
    Abstract: Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: October 17, 2017
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Kathleen Ann Elias, Gregory Landes, Shweta Singh, Wouter Korver, Andrew Walling Drake, Mary Haak-Frendscho, Gyorgy Pal Snell, Vinay Bhaskar